{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:07:19Z","timestamp":1790222839397,"version":"4.1.0"},"reference-count":68,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T00:00:00Z","timestamp":1502841600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Urol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1038\/nrurol.2017.124","type":"journal-article","created":{"date-parts":[[2017,8,16]],"date-time":"2017-08-16T12:40:37Z","timestamp":1502887237000},"page":"620-629","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Concomitant bladder cancer and prostate cancer: challenges and controversies"],"prefix":"10.1038","volume":"14","author":[{"given":"Antonio","family":"Lopez-Beltran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Scarpelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria R.","family":"Raspollini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Montironi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,16]]},"reference":[{"key":"BFnrurol2017124_CR1","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1016\/j.juro.2015.05.091","volume":"194","author":"AM Luchey","year":"2015","unstructured":"Luchey, A. M. et al. Implications of definitive prostate cancer therapy on soft tissue margins and survival in patients undergoing radical cystectomy for bladder urothelial cancer. J. Urol. 194, 1220\u20131225 (2015).","journal-title":"J. Urol."},{"key":"BFnrurol2017124_CR2","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/S0022-5347(05)64157-2","volume":"168","author":"G Vallancien","year":"2002","unstructured":"Vallancien, G. et al. Cystectomy with prostate sparing for bladder cancer in 100 patients: 10 year experience. J. Urol. 168, 2413\u20132417 (2002).","journal-title":"J. Urol."},{"key":"BFnrurol2017124_CR3","doi-asserted-by":"publisher","first-page":"E353","DOI":"10.5489\/cuaj.1532","volume":"8","author":"A Qarro","year":"2014","unstructured":"Qarro, A. et al. Synchronous primary malignancies of the male urogenital tract. Can. Urol. Assoc. J. 8, E353\u2013E355 (2014).","journal-title":"Can. Urol. Assoc. J."},{"key":"BFnrurol2017124_CR4","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1111\/j.1464-410X.2008.08207.x","volume":"103","author":"F Barbisan","year":"2009","unstructured":"Barbisan, F. et al. Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer? BJU Int. 103, 1058\u20131063 (2009).","journal-title":"BJU Int."},{"key":"BFnrurol2017124_CR5","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/nrurol.2015.313","volume":"13","author":"SM Bruinsma","year":"2016","unstructured":"Bruinsma, S. M. et al. Active surveillance for prostate cancer: a narrative review of clinical guidelines. Nat. Rev. Urol. 13, 151\u2013167 (2016)","journal-title":"Nat. Rev. Urol."},{"key":"BFnrurol2017124_CR6","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1464-410X.2006.06660.x","volume":"99","author":"MH Winkler","year":"2007","unstructured":"Winkler, M. H., Livni, N., Mannion, E. M., Hrouda, D. & Christmas, T. Characteristics of incidental prostatic adenocarcinoma in contemporary radical cystoprostatectomy specimens. BJU Int. 99, 554\u2013558 (2007).","journal-title":"BJU Int."},{"key":"BFnrurol2017124_CR7","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.eururo.2007.06.016","volume":"52","author":"R Damiano","year":"2007","unstructured":"Damiano, R. et al. Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis. Eur. Urol. 52, 648\u2013657 (2007).","journal-title":"Eur. Urol."},{"issue":"Suppl. 5","key":"BFnrurol2017124_CR8","first-page":"S27","volume":"179","author":"MP Revelo","year":"2008","unstructured":"Revelo, M. P. et al. Incidence and location of prostate and urothelial carcinoma in prostates from cystoprostatectomies: implication for possible apical sparing surgery. J. Urol. 179 (Suppl. 5) S27\u2013S32 (2008).","journal-title":"J. Urol."},{"key":"BFnrurol2017124_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1309\/AJCP4OCYZBAN9TJU","volume":"131","author":"R Mazzucchelli","year":"2009","unstructured":"Mazzucchelli, R. et al. Is incidentally detected prostate cancer in patients undergoing radical cystoprostatectomy clinically significant? Am. J. Clin. Pathol. 131, 279\u2013283 (2009).","journal-title":"Am. J. Clin. Pathol."},{"key":"BFnrurol2017124_CR10","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/S0022-5347(01)65281-9","volume":"157","author":"TY Chun","year":"1997","unstructured":"Chun, T. Y. Coincidence of bladder and prostate cancer. J. Urol. 157, 65\u201367 (1997).","journal-title":"J. Urol."},{"key":"BFnrurol2017124_CR11","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1159\/000474190","volume":"30","author":"F Abbas","year":"1996","unstructured":"Abbas, F., Hochberg, D., Civantos, F. & Soloway, M. Incidental prostatic adenocarcinoma in patients undergoing radical cystoprostatectomy for bladder cancer. Eur. Urol. 30, 322\u2013326 (1996).","journal-title":"Eur. Urol."},{"key":"BFnrurol2017124_CR12","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/1477-7819-9-81","volume":"9","author":"B Aytac","year":"2011","unstructured":"Aytac, B. & Vuruskan, H. Clinicopathologic features of incidental prostatic adenocarcinoma in radical cystoprostatectomy specimens. World J. Surg. Oncol. 9, 81 (2011).","journal-title":"World J. Surg. Oncol."},{"key":"BFnrurol2017124_CR13","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.eururo.2007.06.016","volume":"52","author":"R Damiano","year":"2007","unstructured":"Damiano, R. et al. Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis. Eur. Urol. 52, 648\u2013657 (2007).","journal-title":"Eur. Urol."},{"key":"BFnrurol2017124_CR14","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1007\/s11255-012-0224-y","volume":"44","author":"M Alsinnawi","year":"2012","unstructured":"Alsinnawi, M. et al. The incidence and relevance of prostate cancer in radial cystoprostatectomy specimens. Int. Urol. Nephrol. 44, 1705\u20131710 (2012).","journal-title":"Int. Urol. Nephrol."},{"key":"BFnrurol2017124_CR15","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11255-009-9578-1","volume":"42","author":"T Kurahashi","year":"2010","unstructured":"Kurahashi, T. et al. Characterization of prostate cancer incidentally detected in radical cystoprostatectomy specimens from Japanese men with bladder cancer. Int. Urol. Nephrol. 42, 73\u201379 (2010).","journal-title":"Int. Urol. Nephrol."},{"key":"BFnrurol2017124_CR16","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1245\/s10434-013-3340-8","volume":"21","author":"G Pignot","year":"2014","unstructured":"Pignot, G. et al. Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French study. Ann. Surg Oncol. 21, 684\u2013690 (2014).","journal-title":"Ann. Surg Oncol."},{"key":"BFnrurol2017124_CR17","doi-asserted-by":"publisher","first-page":"1704","DOI":"10.1016\/j.juro.2013.05.034","volume":"109","author":"HM Bruins","year":"2013","unstructured":"Bruins, H. M. et al. Incidental prostate cancer in patients with bladder urothelial carcinoma: comprehensive analysis of 1476 radical cystoprostatectomy specimen. J. Urol. 109, 1704\u20131709 (2013).","journal-title":"J. Urol."},{"key":"BFnrurol2017124_CR18","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1111\/iju.12073","volume":"20","author":"S Buse","year":"2013","unstructured":"Buse, S. et al. Characterization and risk stratification of prostate cancer in patients undergoing radical cystoprostatectomy. Int. J. Urol. 20, 866\u2013871 (2013).","journal-title":"Int. J. Urol."},{"key":"BFnrurol2017124_CR19","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1007\/s11255-015-1110-1","volume":"47","author":"C Thomas","year":"2015","unstructured":"Thomas, C. et al. Concomitant Gleason Score \u22657 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical Cystoprostatectomy. Int. Urol. Nephrol. 47, 1789\u20131796 (2015).","journal-title":"Int. Urol. Nephrol."},{"issue":"Suppl. 4","key":"BFnrurol2017124_CR20","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1159\/000052579","volume":"39","author":"S Conrad","year":"2001","unstructured":"Conrad, S. et al. Detection and characterization of early prostate cancer by six systematic biopsies and fine needleaspiration cytology in prostates from bladder cancer patients. Eur. Urol. 39 (Suppl. 4) 25\u201329 (2001).","journal-title":"Eur. Urol."},{"key":"BFnrurol2017124_CR21","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.eururo.2005.07.008","volume":"48","author":"NB Delongchamps","year":"2005","unstructured":"Delongchamps, N. B. et al. Outcome of patients with fortuitous prostate cancer after radical cystoprostatectomy for bladder cancer. Eur. Urol. 48, 946\u2013950 (2005).","journal-title":"Eur. Urol."},{"key":"BFnrurol2017124_CR22","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1464-410X.2006.06558.x","volume":"99","author":"M Abdelhady","year":"2007","unstructured":"Abdelhady, M., Abusamra, A., Pautler, S. E., Chin, J. L. & Izawa, J. I. Clinically significant prostate cancer found incidentally in radical cystoprostatectomy specimens. BJU Int. 99, 326\u2013329 (2007).","journal-title":"BJU Int."},{"key":"BFnrurol2017124_CR23","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1111\/j.1745-7262.2008.00420.x","volume":"10","author":"XD Jin","year":"2008","unstructured":"Jin, X. D. et al. Incidental prostate cancer in radical cystoprostatectomy specimens. Asian J. Androl. 10, 809\u2013814 (2008).","journal-title":"Asian J. Androl."},{"key":"BFnrurol2017124_CR24","doi-asserted-by":"publisher","first-page":"1880","DOI":"10.1111\/j.1349-7006.2009.01267.x","volume":"100","author":"T Nakagawa","year":"2009","unstructured":"Nakagawa, T., Kanai, Y., Komiyama, M., Fujimoto, H. & Kakizoe, T. Characteristics of prostate cancers found in specimens removed by radical cystoprostatectomy for bladder cancer and their relationship with serum prostate-specific antigen level. Cancer Sci. 100, 1880\u20131884 (2009).","journal-title":"Cancer Sci."},{"key":"BFnrurol2017124_CR25","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1007\/s11255-014-0647-8","volume":"46","author":"P Pepe","year":"2014","unstructured":"Pepe, P. et al. Preoperative findings, pathological stage PSA recurrence in men with prostate cancer incidentally detected at radical cystectomy: our experience in 242 cases. Int. Urol. Nephrol. 46, 1325\u20131328 (2014).","journal-title":"Int. Urol. Nephrol."},{"key":"BFnrurol2017124_CR26","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1007\/s00428-012-1328-6","volume":"461","author":"HM Fritsche","year":"2012","unstructured":"Fritsche, H. M. et al. Potentially clinically relevant prostate cancer is found frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimen. Virchows Arch. 461, 655\u2013661 (2012).","journal-title":"Virchows Arch."},{"key":"BFnrurol2017124_CR27","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.urology.2004.10.076","volume":"65","author":"A Ruffion","year":"2005","unstructured":"Ruffion, A. et al. Preservation of prostate during radical cystectomy: evaluation of prevalence of prostate cancer associated with bladder cancer. Urology 65, 703\u2013707 (2005).","journal-title":"Urology"},{"key":"BFnrurol2017124_CR28","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1002\/pros.23009","volume":"75","author":"F Siadat","year":"2015","unstructured":"Siadat, F. et al. Not all Gleason pattern 4 prostate cancers are created equal: A study of latent prostatic carcinomas in a cystoprostatectomy and autopsy series. Prostate. 75, 1277\u20131284 (2015).","journal-title":"Prostate."},{"issue":"Suppl. 3","key":"BFnrurol2017124_CR29","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1002\/1097-0142(19930201)71:3+<933::AID-CNCR2820711408>3.0.CO;2-L","volume":"71","author":"TA Stamey","year":"1993","unstructured":"Stamey, T. A. et al. Localized prostate cancer. Relationship of tumor volume to clinical significance for treatment of prostate cancer. Cancer 71(Suppl. 3) 933\u2013938 (1993).","journal-title":"Cancer"},{"key":"BFnrurol2017124_CR30","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1001\/jama.1994.03510290050036","volume":"271","author":"JI Epstein","year":"1994","unstructured":"Epstein, J. I., Walsh, P. C., Carmichael, M. & Brendler, C. B. Pathologicand clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. JAMA 271, 368\u2013374 (1994).","journal-title":"JAMA"},{"key":"BFnrurol2017124_CR31","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.juro.2012.12.021","volume":"190","author":"V Iremashvili","year":"2013","unstructured":"Iremashvili, V., Lokeshwar, S. D., Jorda, M., Pelaez, L. & Soloway, M. S. Prognostic implications of partial sampling of radical prostatectomy specimens: comparison of 3 methods. J. Urol. 190, 84\u201390 (2013).","journal-title":"J. Urol."},{"key":"BFnrurol2017124_CR32","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0090-4295(95)96858-X","volume":"45","author":"MK Terris","year":"1995","unstructured":"Terris, M. K., Haney, D. J., Johnstone, I. M., McNeal, J. E. & Stamey, T. A. Prediction of prostate cancer volume using prostate-specific antigen levels, transrectal ultrasound, and systematic sextant biopsies. Urology 45, 75\u201380 (1995).","journal-title":"Urology"},{"key":"BFnrurol2017124_CR33","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.juro.2008.07.044","volume":"180","author":"C Thomas","year":"2008","unstructured":"Thomas, C. et al. Indications for preoperative prostate biopsy in patients undergoing radical cystoprostatectomy for bladder cancer. J. Urol. 180, 1938\u20131941 (2008).","journal-title":"J. Urol."},{"key":"BFnrurol2017124_CR34","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/j.1464-410X.2009.08739.x","volume":"105","author":"G Gakis","year":"2009","unstructured":"Gakis, G. et al. Incidental prostate cancer at radical cystoprostatectomy: implications for apex-sparing surgery. BJU Int. 105, 468\u2013471 (2009).","journal-title":"BJU Int."},{"key":"BFnrurol2017124_CR35","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1159\/000096333","volume":"77","author":"O Sanli","year":"2006","unstructured":"Sanli, O. et al. Should prostate cancer status be determined in patients undergoing radical cystoprostatectomy? Urol. Int. 77, 307\u2013310 (2006).","journal-title":"Urol. Int."},{"key":"BFnrurol2017124_CR36","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00428-014-1656-9","volume":"465","author":"C Wetterauer","year":"2014","unstructured":"Wetterauer, C. et al. Incidental prostate cancer prevalence at radical cystoprostatectomy, importance of histopathological work-up. Virchows Arch. 465, 629\u2013636 (2014).","journal-title":"Virchows Arch."},{"key":"BFnrurol2017124_CR37","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/S1078-1439(03)00093-0","volume":"22","author":"JF Ward","year":"2004","unstructured":"Ward, J. F. et al. Pathologic characterization of prostate cancers with a very low serum prostate specific antigen (0\u20132 ng\/mL) incidental to cystoprostatectomy: is PSA a useful indicator of clinical significance? Urol. Oncol. 22, 40\u201347 (2004).","journal-title":"Urol. Oncol."},{"key":"BFnrurol2017124_CR38","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.eururo.2008.10.032","volume":"55","author":"R Montironi","year":"2009","unstructured":"Montironi, R. et al. Critical evaluation of the prostate from cystoprostatectomies for bladder cancer: insights from a complete sampling with the whole mount technique. Eur. Urol. 55, 1305\u20131309 (2009).","journal-title":"Eur. Urol."},{"key":"BFnrurol2017124_CR39","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1016\/S0022-5347(01)65705-7","volume":"156","author":"D Esrig","year":"1996","unstructured":"Esrig, D. et al. Transitional cell carcinoma involving the prostate with proposed staging classification for stromal invasion. J. Urol. 156, 1071\u20131076 (1996).","journal-title":"J. Urol."},{"key":"BFnrurol2017124_CR40","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.urology.2010.01.090","volume":"76","author":"I Ouzaid","year":"2010","unstructured":"Ouzaid, I., Cussenot, O. & Roupr\u00eat, M. Prostate-sparing cystectomy for bladder cancer: A step toward a deade-end. Urology 76, 260\u2013263 (2010).","journal-title":"Urology"},{"key":"BFnrurol2017124_CR41","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/j.1464-410X.2004.05097.x","volume":"94","author":"H Botto","year":"2004","unstructured":"Botto, H. et al. Prostate capsule and seminal-sparing cystectomy for bladder carcinoma: initial results for selected patients. BJU Int. 94, 1021\u20131025 (2004).","journal-title":"BJU Int."},{"key":"BFnrurol2017124_CR42","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.urolonc.2007.12.014","volume":"27","author":"JP Stein","year":"2009","unstructured":"Stein, J. P., Hautmann, R. E., Penson, D. & Skinner, D. G. Prostate-sparing cystectomy: A review of the oncologic and functional outcomes. Contraindicated in patients with bladder cancer. Urol. Onc. 27, 466\u2013472 (2009).","journal-title":"Urol. Onc."},{"key":"BFnrurol2017124_CR43","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.eururo.2007.07.031","volume":"53","author":"JA Pettus","year":"2008","unstructured":"Pettus, J. A. et al. Risk assessment of prostatic pathology in patients undergoing radical cystoprostatectomy. Eur. Urol. 53, 370\u2013375 (2008).","journal-title":"Eur. Urol."},{"key":"BFnrurol2017124_CR44","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.urolonc.2008.03.018","volume":"26","author":"JC Kefer","year":"2008","unstructured":"Kefer, J. C. & Campbell, S. C. Current status of prostate-sparing cystectomy. Urol. Onc. 26, 486\u2013493 (2008).","journal-title":"Urol. Onc."},{"key":"BFnrurol2017124_CR45","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1016\/j.juro.2008.01.112","volume":"179","author":"F Rozet","year":"2008","unstructured":"Rozet, F. et al. Oncological evaluation of prostate sparing cystectomy: The Montsouris long-term results. J. Urol. 179, 2170\u20132175 (2008).","journal-title":"J. Urol."},{"key":"BFnrurol2017124_CR46","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1111\/j.1464-410X.2011.10612.x","volume":"109","author":"A Shukla-Dave","year":"2012","unstructured":"Shukla-Dave, A. et al. Preoperative nomograms incorporating magnetic resonance imaging and spectroscopy for prediction of insignificant prostate cancer. BJU Int. 109, 1315\u20131322 (2012).","journal-title":"BJU Int."},{"key":"BFnrurol2017124_CR47","first-page":"395","volume":"35","author":"P Pepe","year":"2015","unstructured":"Pepe, P., Dibenedetto, G., Garufi, A., Priolo, G. & Pennisi, M. Multiparametric pelvic MRI accuracy in diagnosing clinically significant prostate cancer in the reevaluation of biopsy microfocal tumor. Anticancer Res. 35, 395\u2013399 (2015).","journal-title":"Anticancer Res."},{"key":"BFnrurol2017124_CR48","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/jnci\/91.12.1017","volume":"91","author":"BF Hankey","year":"1999","unstructured":"Hankey, B. F. et al. Cancer surveillance series: interpreting trends in prostate cancer\u2014part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J. Natl Cancer Inst. 91, 1017\u20131024 (1999).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrurol2017124_CR49","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.humpath.2006.05.009","volume":"37","author":"A Lopez-Beltran","year":"2006","unstructured":"Lopez-Beltran, A. & Cheng, L. Histologic variants of urothelial carcinoma: differential diagnosis and clinical implications. Hum. Pathol. 37, 1371\u20131388 (2006).","journal-title":"Hum. Pathol."},{"key":"BFnrurol2017124_CR50","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1097\/PAS.0b013e318268ccc1","volume":"37","author":"V Iremashvili","year":"2013","unstructured":"Iremashvili, V. et al. Partial sampling of radical prostatectomy specimens: detection of positive margins and extraprostatic extension. Am. J. Surg. Pathol. 37, 219\u2013225 (2013)","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnrurol2017124_CR51","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1016\/j.humpath.2006.04.004","volume":"37","author":"R Montironi","year":"2006","unstructured":"Montironi, R. et al. HER2 expression and gene amplification in pT2a Gleason score 6 prostate cancer incidentally detected in cystoprostatectomies: comparison with clinically detected androgen-dependent and androgenindependent cancer. Hum. Pathol. 37, 1137\u20131144 (2006).","journal-title":"Hum. Pathol."},{"key":"BFnrurol2017124_CR52","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1309\/P065G467FKKUJDE5","volume":"128","author":"A Santinelli","year":"2007","unstructured":"Santinelli, A. et al. \u03b1-methylacylcoenzyme A racemase, Ki-67, and topoisomerase II\u03b1 incystoprostatectomies with incidental prostate cancer. Am. J. Clin. Pathol. 128, 657\u2013666 (2007).","journal-title":"Am. J. Clin. Pathol."},{"key":"BFnrurol2017124_CR53","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3109\/00365599.2012.756929","volume":"47","author":"G Gakis","year":"2013","unstructured":"Gakis, G., Stenz, A. & Renninger, M. Evolution of the concept of androgen-sensitive bladder cancer. Scand. J. Urol. 47, 173\u2013178 (2013).","journal-title":"Scand. J. Urol."},{"key":"BFnrurol2017124_CR54","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1093\/jnci\/djk113","volume":"99","author":"H Miyamoto","year":"2007","unstructured":"Miyamoto, H. et al. Promotion of bladder cancer development and progression by androgen receptor signals. J. Natl Cancer Inst. 99, 558\u2013568 (2007).","journal-title":"J. Natl Cancer Inst."},{"key":"BFnrurol2017124_CR55","doi-asserted-by":"crossref","first-page":"12665","DOI":"10.18632\/oncotarget.2851","volume":"30","author":"K Izumi","year":"2014","unstructured":"Izumi, K. et al. Androgen deprivation therapy prevents bladder cancer recurrence. Oncotarget 30, 12665\u201312674 (2014).","journal-title":"Oncotarget"},{"key":"BFnrurol2017124_CR56","doi-asserted-by":"publisher","first-page":"e103791","DOI":"10.1371\/journal.pone.0103791","volume":"9","author":"S Hong","year":"2014","unstructured":"Hong, S. et al. Is bladder tumor location associated with prostate cancer detection after intravesical bacillus Calmette\u2013Guerin instillation? PLoS ONE 9, e103791 (2014).","journal-title":"PLoS ONE"},{"key":"BFnrurol2017124_CR57","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nrc2090","volume":"7","author":"AM De Marzo","year":"2007","unstructured":"De Marzo, A. M. et al. Inflammation in prostate carcinogenesis. Nat. Rev. Cancer. 7, 256\u2013269 (2007).","journal-title":"Nat. Rev. Cancer."},{"key":"BFnrurol2017124_CR58","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1111\/j.1365-2559.2011.04033.x","volume":"60","author":"KS Sfanos","year":"2012","unstructured":"Sfanos, K. S. & De Marzo, A. M. Prostate cancer and inflammation: the evidence. Histopathology 60, 199\u2013215 (2012).","journal-title":"Histopathology"},{"key":"BFnrurol2017124_CR59","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0022-5347(17)42864-3","volume":"139","author":"TR Pritchett","year":"1988","unstructured":"Pritchett, T. R. et al. Unsuspected prostatic adenocarcinoma in patients who have undergone radical cystoprostatectomy for transitional cell carcinoma of the bladder. J. Urol. 139, 1214\u20131216 (1988).","journal-title":"J. Urol."},{"key":"BFnrurol2017124_CR60","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1002\/pros.21415","volume":"72","author":"T Wolters","year":"2012","unstructured":"Wolters, T. et al. Comparison of incidentally detected prostate cancer with screen-detected prostate cancer treated by prostatectomy. Prostate 72, 108\u2013115 (2012).","journal-title":"Prostate"},{"key":"BFnrurol2017124_CR61","first-page":"139","volume":"37","author":"E Pacella","year":"2015","unstructured":"Pacella, E. et al. Prostatic and urothelial metastasis in the same lymph node: a case report. Anal. Quant. Cytopathol. Histpathol. 37, 139\u2013143 (2015).","journal-title":"Anal. Quant. Cytopathol. Histpathol."},{"key":"BFnrurol2017124_CR62","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/s00428-005-0102-4","volume":"448","author":"A Lopez-Beltran","year":"2006","unstructured":"Lopez-Beltran, A., Mikuz, G., Luque, R. J., Mazzucchelli, R. & Montironi, R. Current practice of Gleason grading of prostate carcinoma. Virchows Arch. 448, 111\u2013118 (2006).","journal-title":"Virchows Arch."},{"key":"BFnrurol2017124_CR63","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1097\/01.pas.0000173646.99337.b1","volume":"29","author":"JI Epstein","year":"2005","unstructured":"Epstein, J. I. et al. The 2005 International Society of Urological Pathology (ISUP) consensus conference of Gleason grading of prostatic carcinoma. Am. J. Surg. Pathol. 29, 1228 (2005).","journal-title":"Am. J. Surg. Pathol."},{"key":"BFnrurol2017124_CR64","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.prnil.2016.06.002","volume":"4","author":"JB Kaelberer","year":"2016","unstructured":"Kaelberer, J. B. et al. Incidental prostate cancer diagnosed at radical cystoprostatectomy for bladder cancer: disease-specific outcomes and survival. Prostate Int. 4, 107\u2013112 (2016).","journal-title":"Prostate Int."},{"key":"BFnrurol2017124_CR65","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.eururo.2016.08.003","volume":"71","author":"N Mottet","year":"2017","unstructured":"Mottet, N. et al. EAU-ESTRO-SIOG guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent. Eur. Urol. 71, 618\u2013629 (2017).","journal-title":"Eur. Urol."},{"key":"BFnrurol2017124_CR66","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1016\/j.eururo.2016.06.020","volume":"71","author":"J Alfred Witjes","year":"2017","unstructured":"Alfred Witjes, J. et al. Updated 2016 EAU guidelines on muscle-invasive and metastatic bladder cancer. Eur. Urol. 71, 462\u2013475 (2017).","journal-title":"Eur. Urol."},{"key":"BFnrurol2017124_CR67","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","volume":"71","author":"M Babjuk","year":"2017","unstructured":"Babjuk, M. et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2016. Eur. Urol. 71, 447\u2013461 (2017).","journal-title":"Eur. Urol."},{"key":"BFnrurol2017124_CR68","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1007\/s00428-016-1981-2","volume":"469","author":"TA Flood","year":"2017","unstructured":"Flood, T. A. et al. Utility of Gleason pattern 4 morphologies detected on transrectal ultrasound (TRUS)-guided biopsies for prediction of upgrading or upstaging in Gleason score 3 + 4 = 7 prostate cancer. Virchows Arch. 469, 313\u2013319 (2017).","journal-title":"Virchows Arch."}],"container-title":["Nature Reviews Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2017.124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2017.124","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/doifinder\/10.1038\/nrurol.2017.124","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/www.nature.com\/articles\/nrurol.2017.124.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T04:18:02Z","timestamp":1684469882000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrurol.2017.124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,16]]},"references-count":68,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["BFnrurol2017124"],"URL":"https:\/\/doi.org\/10.1038\/nrurol.2017.124","relation":{},"ISSN":["1759-4812","1759-4820"],"issn-type":[{"value":"1759-4812","type":"print"},{"value":"1759-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,16]]},"assertion":[{"value":"16 August 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}